95 related articles for article (PubMed ID: 11389908)
1. The predicted beta12-beta13 loop is important for inhibition of PP2Acalpha by the antitumor drug fostriecin.
Evans DR; Simon JA
FEBS Lett; 2001 Jun; 498(1):110-5. PubMed ID: 11389908
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship studies of fostriecin, cytostatin, and key analogs, with PP1, PP2A, PP5, and( beta12-beta13)-chimeras (PP1/PP2A and PP5/PP2A), provide further insight into the inhibitory actions of fostriecin family inhibitors.
Swingle MR; Amable L; Lawhorn BG; Buck SB; Burke CP; Ratti P; Fischer KL; Boger DL; Honkanen RE
J Pharmacol Exp Ther; 2009 Oct; 331(1):45-53. PubMed ID: 19592665
[TBL] [Abstract][Full Text] [Related]
3. Importance of the beta12-beta13 loop in protein phosphatase-1 catalytic subunit for inhibition by toxins and mammalian protein inhibitors.
Connor JH; Kleeman T; Barik S; Honkanen RE; Shenolikar S
J Biol Chem; 1999 Aug; 274(32):22366-72. PubMed ID: 10428807
[TBL] [Abstract][Full Text] [Related]
4. Fundamental role of the fostriecin unsaturated lactone and implications for selective protein phosphatase inhibition.
Buck SB; Hardouin C; Ichikawa S; Soenen DR; Gauss CM; Hwang I; Swingle MR; Bonness KM; Honkanen RE; Boger DL
J Am Chem Soc; 2003 Dec; 125(51):15694-5. PubMed ID: 14677930
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure and mutagenesis of a protein phosphatase-1:calcineurin hybrid elucidate the role of the beta12-beta13 loop in inhibitor binding.
Maynes JT; Perreault KR; Cherney MM; Luu HA; James MN; Holmes CF
J Biol Chem; 2004 Oct; 279(41):43198-206. PubMed ID: 15280359
[TBL] [Abstract][Full Text] [Related]
6. Fostriecin, an antitumor antibiotic with inhibitory activity against serine/threonine protein phosphatases types 1 (PP1) and 2A (PP2A), is highly selective for PP2A.
Walsh AH; Cheng A; Honkanen RE
FEBS Lett; 1997 Oct; 416(3):230-4. PubMed ID: 9373158
[TBL] [Abstract][Full Text] [Related]
7. The beta12-beta13 loop of protein phosphatase-1 is involved in activity regulation.
Xie X; Xue C; Huang W; Wei Q
IUBMB Life; 2006 Aug; 58(8):487-92. PubMed ID: 16916787
[TBL] [Abstract][Full Text] [Related]
8. Inhibitor-1 interaction domain that mediates the inhibition of protein phosphatase-1.
Connor JH; Quan HN; Ramaswamy NT; Zhang L; Barik S; Zheng J; Cannon JF; Lee EY; Shenolikar S
J Biol Chem; 1998 Oct; 273(42):27716-24. PubMed ID: 9765309
[TBL] [Abstract][Full Text] [Related]
9. Fostriecin: chemistry and biology.
Lewy DS; Gauss CM; Soenen DR; Boger DL
Curr Med Chem; 2002 Nov; 9(22):2005-32. PubMed ID: 12369868
[TBL] [Abstract][Full Text] [Related]
10. Fostriecin-mediated G2-M-phase growth arrest correlates with abnormal centrosome replication, the formation of aberrant mitotic spindles, and the inhibition of serine/threonine protein phosphatase activity.
Cheng A; Balczon R; Zuo Z; Koons JS; Walsh AH; Honkanen RE
Cancer Res; 1998 Aug; 58(16):3611-9. PubMed ID: 9721869
[TBL] [Abstract][Full Text] [Related]
11. Suppression of Ser/Thr phosphatase 4 (PP4C/PPP4C) mimics a novel post-mitotic action of fostriecin, producing mitotic slippage followed by tetraploid cell death.
Theobald B; Bonness K; Musiyenko A; Andrews JF; Urban G; Huang X; Dean NM; Honkanen RE
Mol Cancer Res; 2013 Aug; 11(8):845-55. PubMed ID: 23671329
[TBL] [Abstract][Full Text] [Related]
12. Important role for phylogenetically invariant PP2Acalpha active site and C-terminal residues revealed by mutational analysis in Saccharomyces cerevisiae.
Evans DR; Hemmings BA
Genetics; 2000 Sep; 156(1):21-9. PubMed ID: 10978272
[TBL] [Abstract][Full Text] [Related]
13. Purification of protein phosphatase 4 catalytic subunit: inhibition by the antitumour drug fostriecin and other tumour suppressors and promoters.
Hastie CJ; Cohen PT
FEBS Lett; 1998 Jul; 431(3):357-61. PubMed ID: 9714542
[TBL] [Abstract][Full Text] [Related]
14. Nuclear localization of protein phosphatase 5 is dependent on the carboxy-terminal region.
Borthwick EB; Zeke T; Prescott AR; Cohen PT
FEBS Lett; 2001 Mar; 491(3):279-84. PubMed ID: 11240142
[TBL] [Abstract][Full Text] [Related]
15. Protein phosphatase 1 regulation by inhibitors and targeting subunits.
Watanabe T; Huang HB; Horiuchi A; da Cruze Silva EF; Hsieh-Wilson L; Allen PB; Shenolikar S; Greengard P; Nairn AC
Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3080-5. PubMed ID: 11248035
[TBL] [Abstract][Full Text] [Related]
16. Antitumor antibiotic fostriecin covalently binds to cysteine-269 residue of protein phosphatase 2A catalytic subunit in mammalian cells.
Takeuchi T; Takahashi N; Ishi K; Kusayanagi T; Kuramochi K; Sugawara F
Bioorg Med Chem; 2009 Dec; 17(23):8113-22. PubMed ID: 19857968
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of PP2A, but not PP5, mediates p53 activation by low levels of okadaic acid in rat liver epithelial cells.
Messner DJ; Romeo C; Boynton A; Rossie S
J Cell Biochem; 2006 Sep; 99(1):241-55. PubMed ID: 16598789
[TBL] [Abstract][Full Text] [Related]
18. Antitumor drug fostriecin inhibits the mitotic entry checkpoint and protein phosphatases 1 and 2A.
Roberge M; Tudan C; Hung SM; Harder KW; Jirik FR; Anderson H
Cancer Res; 1994 Dec; 54(23):6115-21. PubMed ID: 7954457
[TBL] [Abstract][Full Text] [Related]
19. The beta12-beta13 loop is a key regulatory element for the activity and properties of the catalytic domain of protein phosphatase 1 and 2B.
Xie XJ; Xue CZ; Huang W; Yu DY; Wei Q
Biol Chem; 2006; 387(10-11):1461-7. PubMed ID: 17081120
[TBL] [Abstract][Full Text] [Related]
20. CRHSP-24 phosphorylation is regulated by multiple signaling pathways in pancreatic acinar cells.
Schäfer C; Steffen H; Krzykowski KJ; Göke B; Groblewski GE
Am J Physiol Gastrointest Liver Physiol; 2003 Oct; 285(4):G726-34. PubMed ID: 12801884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
